Cargando…

High-flow nasal cannula for reducing hypoxemic events in patients undergoing bronchoscopy: A systematic review and meta-analysis of randomized trials

BACKGROUND: Patients undergoing bronchoscopic procedures may develop hypoxemia and severe complications. High-flow nasal cannula (HFNC) may prevent hypoxemic events during bronchoscopy. We conducted a systematic review of randomized controlled trials (RCTs) to evaluate the effectiveness of HFNC in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Chien-Ling, Chiang, Ling-Ling, Tam, Ka-Wai, Chen, Tzu-Tao, Hu, Ming-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635390/
https://www.ncbi.nlm.nih.gov/pubmed/34851996
http://dx.doi.org/10.1371/journal.pone.0260716
_version_ 1784608293330616320
author Su, Chien-Ling
Chiang, Ling-Ling
Tam, Ka-Wai
Chen, Tzu-Tao
Hu, Ming-Chi
author_facet Su, Chien-Ling
Chiang, Ling-Ling
Tam, Ka-Wai
Chen, Tzu-Tao
Hu, Ming-Chi
author_sort Su, Chien-Ling
collection PubMed
description BACKGROUND: Patients undergoing bronchoscopic procedures may develop hypoxemia and severe complications. High-flow nasal cannula (HFNC) may prevent hypoxemic events during bronchoscopy. We conducted a systematic review of randomized controlled trials (RCTs) to evaluate the effectiveness of HFNC in these patients. METHODS: We conducted a search in PubMed, Embase, and the Cochrane Library for RCTs published before November 2021. Individual effect sizes were standardized, and a meta-analysis was performed to calculate the pooled effect size using random-effects models. The primary outcome was the incidence of hypoxemic events (oxygen saturation [SpO(2)] < 90%) during bronchoscopy. Secondary outcomes included the incidence of interrupted bronchoscopy due to desaturation, lowest SpO(2) during bronchoscopy, partial pressure of oxygen (PaO(2)), partial pressure of carbon dioxide (PaCO(2)), end-tidal CO(2) (EtCO(2)) at the end of bronchoscopy, and the incidence of intubation after the procedure. RESULTS: Five trials involving 257 patients were reviewed. The incidence of hypoxemic events was lower in the HFNC group than in the conventional oxygen therapy group (risk ratio, 0.25; 95% confidence interval [CI], 0.14–0.42). The lowest SpO(2) during the procedure was significantly higher in the HFNC group than in the conventional oxygen therapy group (weighted mean difference [WMD], 7.12; 95% CI, 5.39–8.84). PaO(2) at the end of the procedure was significantly higher in the HFNC group than in the conventional oxygen therapy group (WMD, 20.36; 95% CI, 0.30–40.42). The incidence of interrupted bronchoscopy due to desaturation, PaCO(2) and EtCO(2) at the end of the procedure, and the incidence of intubation after the procedure were not significantly different between groups. CONCLUSIONS: HFNC may reduce the incidence of hypoxemic events and improve oxygenation in patients undergoing bronchoscopy.
format Online
Article
Text
id pubmed-8635390
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-86353902021-12-02 High-flow nasal cannula for reducing hypoxemic events in patients undergoing bronchoscopy: A systematic review and meta-analysis of randomized trials Su, Chien-Ling Chiang, Ling-Ling Tam, Ka-Wai Chen, Tzu-Tao Hu, Ming-Chi PLoS One Research Article BACKGROUND: Patients undergoing bronchoscopic procedures may develop hypoxemia and severe complications. High-flow nasal cannula (HFNC) may prevent hypoxemic events during bronchoscopy. We conducted a systematic review of randomized controlled trials (RCTs) to evaluate the effectiveness of HFNC in these patients. METHODS: We conducted a search in PubMed, Embase, and the Cochrane Library for RCTs published before November 2021. Individual effect sizes were standardized, and a meta-analysis was performed to calculate the pooled effect size using random-effects models. The primary outcome was the incidence of hypoxemic events (oxygen saturation [SpO(2)] < 90%) during bronchoscopy. Secondary outcomes included the incidence of interrupted bronchoscopy due to desaturation, lowest SpO(2) during bronchoscopy, partial pressure of oxygen (PaO(2)), partial pressure of carbon dioxide (PaCO(2)), end-tidal CO(2) (EtCO(2)) at the end of bronchoscopy, and the incidence of intubation after the procedure. RESULTS: Five trials involving 257 patients were reviewed. The incidence of hypoxemic events was lower in the HFNC group than in the conventional oxygen therapy group (risk ratio, 0.25; 95% confidence interval [CI], 0.14–0.42). The lowest SpO(2) during the procedure was significantly higher in the HFNC group than in the conventional oxygen therapy group (weighted mean difference [WMD], 7.12; 95% CI, 5.39–8.84). PaO(2) at the end of the procedure was significantly higher in the HFNC group than in the conventional oxygen therapy group (WMD, 20.36; 95% CI, 0.30–40.42). The incidence of interrupted bronchoscopy due to desaturation, PaCO(2) and EtCO(2) at the end of the procedure, and the incidence of intubation after the procedure were not significantly different between groups. CONCLUSIONS: HFNC may reduce the incidence of hypoxemic events and improve oxygenation in patients undergoing bronchoscopy. Public Library of Science 2021-12-01 /pmc/articles/PMC8635390/ /pubmed/34851996 http://dx.doi.org/10.1371/journal.pone.0260716 Text en © 2021 Su et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Su, Chien-Ling
Chiang, Ling-Ling
Tam, Ka-Wai
Chen, Tzu-Tao
Hu, Ming-Chi
High-flow nasal cannula for reducing hypoxemic events in patients undergoing bronchoscopy: A systematic review and meta-analysis of randomized trials
title High-flow nasal cannula for reducing hypoxemic events in patients undergoing bronchoscopy: A systematic review and meta-analysis of randomized trials
title_full High-flow nasal cannula for reducing hypoxemic events in patients undergoing bronchoscopy: A systematic review and meta-analysis of randomized trials
title_fullStr High-flow nasal cannula for reducing hypoxemic events in patients undergoing bronchoscopy: A systematic review and meta-analysis of randomized trials
title_full_unstemmed High-flow nasal cannula for reducing hypoxemic events in patients undergoing bronchoscopy: A systematic review and meta-analysis of randomized trials
title_short High-flow nasal cannula for reducing hypoxemic events in patients undergoing bronchoscopy: A systematic review and meta-analysis of randomized trials
title_sort high-flow nasal cannula for reducing hypoxemic events in patients undergoing bronchoscopy: a systematic review and meta-analysis of randomized trials
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635390/
https://www.ncbi.nlm.nih.gov/pubmed/34851996
http://dx.doi.org/10.1371/journal.pone.0260716
work_keys_str_mv AT suchienling highflownasalcannulaforreducinghypoxemiceventsinpatientsundergoingbronchoscopyasystematicreviewandmetaanalysisofrandomizedtrials
AT chianglingling highflownasalcannulaforreducinghypoxemiceventsinpatientsundergoingbronchoscopyasystematicreviewandmetaanalysisofrandomizedtrials
AT tamkawai highflownasalcannulaforreducinghypoxemiceventsinpatientsundergoingbronchoscopyasystematicreviewandmetaanalysisofrandomizedtrials
AT chentzutao highflownasalcannulaforreducinghypoxemiceventsinpatientsundergoingbronchoscopyasystematicreviewandmetaanalysisofrandomizedtrials
AT humingchi highflownasalcannulaforreducinghypoxemiceventsinpatientsundergoingbronchoscopyasystematicreviewandmetaanalysisofrandomizedtrials